Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine in severe traumatic brain injury
IRCT20220220054079N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Deferoxamine with Placebo (2 arms). Primary endpoint: Glasgow Outcome Scale. Started Dec 2022; status: completed.
02
Drugs
deferoxamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20220220054079N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220220054079N1.